• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

侵袭性曲霉病的治疗失败:两性霉素B治疗后深部组织分离株的敏感性

Treatment failure in invasive aspergillosis: susceptibility of deep tissue isolates following treatment with amphotericin B.

作者信息

Paterson P J, Seaton S, Prentice H G, Kibbler C C

机构信息

Departments of Microbiology and Haematology, Royal Free and University College Medical School, Royal Free Campus and Royal Free Hospital, Pond Street, London NW3 2QG, UK.

出版信息

J Antimicrob Chemother. 2003 Nov;52(5):873-6. doi: 10.1093/jac/dkg434. Epub 2003 Sep 30.

DOI:10.1093/jac/dkg434
PMID:14519673
Abstract

OBJECTIVES

To determine whether treatment failure in invasive aspergillosis (IA) is the result of resistance of Aspergillus spp. isolates to amphotericin B.

METHODS

Six Aspergillus fumigatus and six Aspergillus flavus isolates cultured from deep tissue biopsies in 11 patients with haematological malignancies during 1991-1998 were tested. A method based on the NCCLS M38-A broth microdilution method, with colorimetric determination of MICs, was used to determine the MICs of amphotericin B and itraconazole.

RESULTS

All A. fumigatus isolates were susceptible to amphotericin B (MIC 0.25-0.5 mg/L), as were three A. flavus isolates (MIC 1 mg/L), but three were less susceptible (MIC 2 mg/L). All isolates were susceptible to itraconazole (MIC 0.125-0.25 mg/L). All patients had been treated with amphotericin B, having received a median of 12 days of treatment when the tissue was obtained.

CONCLUSION

The difficulty in treating IA may not be because of the susceptibility of the isolates, but because of poor penetration of antifungal agents into infected tissue. Aspergillus spp. invade blood vessels causing thrombosis and tissue infarction, and therefore it may be difficult for antifungal drugs to exceed MICs in infected tissues. This highlights the need for different treatment strategies, such as surgery and the administration of cytokines.

摘要

目的

确定侵袭性曲霉病(IA)治疗失败是否是由于曲霉属分离株对两性霉素B耐药所致。

方法

对1991年至1998年间从11例血液系统恶性肿瘤患者的深部组织活检中培养出的6株烟曲霉和6株黄曲霉分离株进行检测。采用基于NCCLS M38 - A肉汤微量稀释法并通过比色法测定最低抑菌浓度(MIC)的方法,来确定两性霉素B和伊曲康唑的MIC。

结果

所有烟曲霉分离株对两性霉素B敏感(MIC为0.25 - 0.5mg/L),3株黄曲霉分离株也敏感(MIC为1mg/L),但有3株敏感性较差(MIC为2mg/L)。所有分离株对伊曲康唑敏感(MIC为0.125 - 0.25mg/L)。所有患者均接受过两性霉素B治疗,获取组织时接受治疗的中位天数为12天。

结论

IA治疗困难可能并非因为分离株的敏感性,而是因为抗真菌药物难以渗透到感染组织中。曲霉属侵入血管导致血栓形成和组织梗死,因此抗真菌药物可能难以在感染组织中超过MIC。这凸显了需要采用不同的治疗策略,如手术和给予细胞因子。

相似文献

1
Treatment failure in invasive aspergillosis: susceptibility of deep tissue isolates following treatment with amphotericin B.侵袭性曲霉病的治疗失败:两性霉素B治疗后深部组织分离株的敏感性
J Antimicrob Chemother. 2003 Nov;52(5):873-6. doi: 10.1093/jac/dkg434. Epub 2003 Sep 30.
2
Comparison of the Sensititre YeastOne colorimetric antifungal panel and Etest with the NCCLS M38-A method to determine the activity of amphotericin B and itraconazole against clinical isolates of Aspergillus spp.使用Sensititre YeastOne比色法抗真菌药敏板和Etest,与NCCLS M38 - A方法比较,以确定两性霉素B和伊曲康唑对曲霉属临床分离株的活性
J Antimicrob Chemother. 2003 Sep;52(3):365-70. doi: 10.1093/jac/dkg384. Epub 2003 Aug 13.
3
In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole.引起耳霉菌病的曲霉属真菌对两性霉素B、伏立康唑和伊曲康唑的体外药敏试验
Mycoses. 2007 Nov;50(6):447-50. doi: 10.1111/j.1439-0507.2007.01409.x.
4
Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B.米卡芬净(FK463)对一株耐伊曲康唑的烟曲霉以及一株对两性霉素B表现出体内耐药性的土曲霉的活性。
J Antimicrob Chemother. 2003 Apr;51(4):913-9. doi: 10.1093/jac/dkg185. Epub 2003 Mar 13.
5
Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma.从一名肺曲菌球患者连续分离出的烟曲霉中cyp51A基因的突变及其对伊曲康唑的敏感性
J Antimicrob Chemother. 2005 Jan;55(1):31-7. doi: 10.1093/jac/dkh507. Epub 2004 Nov 24.
6
Comparison of Sensititre YeastOne with the NCCLS M38-A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus.比较Sensititre YeastOne法与NCCLS M38 - A微量稀释法测定两性霉素B、伏立康唑和伊曲康唑对烟曲霉临床分离株的活性。
Diagn Microbiol Infect Dis. 2006 Sep;56(1):53-5. doi: 10.1016/j.diagmicrobio.2006.03.004. Epub 2006 May 2.
7
Susceptibility testing of sequential isolates of Aspergillus fumigatus recovered from treated patients.对从接受治疗的患者身上分离出的烟曲霉连续菌株进行药敏试验。
J Med Microbiol. 2004 Feb;53(Pt 2):129-134. doi: 10.1099/jmm.0.05326-0.
8
In vitro activities of amphotericin B and AmBisome against Aspergillus isolates recovered from Italian patients treated for haematological malignancies.体外研究两性霉素 B 和两性霉素 B 脂质体对意大利血液系统恶性肿瘤患者分离的曲霉菌的活性。
Int J Antimicrob Agents. 2012 May;39(5):440-3. doi: 10.1016/j.ijantimicag.2012.01.013. Epub 2012 Mar 17.
9
Increased frequency of non-fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for aspergilli.在两性霉素B或三唑类药物预先暴露且曲霉培养呈阳性的癌症患者中,非烟曲霉属物种的频率增加。
Diagn Microbiol Infect Dis. 2005 May;52(1):15-20. doi: 10.1016/j.diagmicrobio.2005.01.001.
10
Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.台湾念珠菌属、新型隐球菌及曲霉菌属临床分离株的抗真菌药敏性:2003年台湾多中心抗菌药物耐药性监测计划数据
Antimicrob Agents Chemother. 2005 Feb;49(2):512-7. doi: 10.1128/AAC.49.2.512-517.2005.

引用本文的文献

1
Potential Implication of Azole Persistence in the Treatment Failure of Two Haematological Patients Infected with .唑类药物持续存在对两名感染……的血液学患者治疗失败的潜在影响
J Fungi (Basel). 2023 Jul 30;9(8):805. doi: 10.3390/jof9080805.
2
Diagnosis and Treatment of Invasive Aspergillosis Caused by Non- spp.非烟曲霉属引起的侵袭性曲霉病的诊断与治疗
J Fungi (Basel). 2023 Apr 21;9(4):500. doi: 10.3390/jof9040500.
3
Invasive in the Intensive Care Unit.重症监护病房中的侵入性操作。
Diagnostics (Basel). 2022 Nov 6;12(11):2712. doi: 10.3390/diagnostics12112712.
4
Filamentous fungal biofilms: Conserved and unique aspects of extracellular matrix composition, mechanisms of drug resistance and regulatory networks in Aspergillus fumigatus.丝状真菌生物膜:烟曲霉细胞外基质组成、耐药机制和调控网络的保守和独特方面。
NPJ Biofilms Microbiomes. 2022 Oct 19;8(1):83. doi: 10.1038/s41522-022-00347-3.
5
Amphotericin B resistance in Leishmania mexicana: Alterations to sterol metabolism and oxidative stress response.墨西哥利什曼原虫的两性霉素 B 耐药性:固醇代谢和氧化应激反应的改变。
PLoS Negl Trop Dis. 2022 Sep 28;16(9):e0010779. doi: 10.1371/journal.pntd.0010779. eCollection 2022 Sep.
6
Antifungal Macrocycle Antibiotic Amphotericin B-Its Present and Future. Multidisciplinary Perspective for the Use in the Medical Practice.抗真菌大环内酯类抗生素两性霉素B——其现状与未来。医学实践应用的多学科视角。
Biochem Mosc Suppl B Biomed Chem. 2022;16(1):1-12. doi: 10.1134/S1990750822010024. Epub 2022 Feb 14.
7
Fungal biofilm architecture produces hypoxic microenvironments that drive antifungal resistance.真菌生物膜结构产生低氧微环境,从而导致抗真菌耐药性。
Proc Natl Acad Sci U S A. 2020 Sep 8;117(36):22473-22483. doi: 10.1073/pnas.2003700117. Epub 2020 Aug 26.
8
Efficacy of Voriconazole against Aspergillus fumigatus Infection Depends on Host Immune Function.伏立康唑治疗烟曲霉感染的疗效取决于宿主免疫功能。
Antimicrob Agents Chemother. 2020 Jan 27;64(2). doi: 10.1128/AAC.00917-19.
9
Beyond tissue concentrations: antifungal penetration at the site of infection.超越组织浓度:感染部位的抗真菌药物渗透
Med Mycol. 2019 Apr 1;57(Supplement_2):S161-S167. doi: 10.1093/mmy/myy067.
10
Reversing resistance: different routes and common themes across pathogens.逆转耐药性:病原体的不同途径与共同主题
Proc Biol Sci. 2017 Sep 27;284(1863). doi: 10.1098/rspb.2017.1619.